Concordia International (CXRX) Under Heavy Pressure Amid Proposed UK Drug Price Bill

September 16, 2016 9:37 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Concordia International (NASDAQ: CXRX) slammed which is attributed to a new proposed UK bill to control drug prices. Shares down 13.8%.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment